European Registry of Pancreatic Exocrine Insufficiency

2nd May 2023

European Registry of Pancreatic Exocrine Insufficiency

The European Registry of Pancreatic Exocrine Insufficiency is coordinated from the Department of Gastroenterology and Hepatology of the University Hospital of Santiago de Compostela, Spain (Prof. J. Enrique Domínguez-Muñoz). For more information, and if you would like to take part in this project, please contact Xurxo Martínez-Seara (, who is the Registry coordinator. 

Study design. Prospective cross-sectional observational study of patients diagnosed with PEI, in whom PERT is prescribed. PERT should be optimized according to current clinical guidelines in order to achieve symptom relief and normalization of the patients’ nutritional status.

Setting. Multicentre European study.

Patients. Patients older than 18 years diagnosed with PEI of any aetiology (acute pancreatitis, chronic pancreatitis, cystic fibrosis, pancreatic cancer, pancreatic surgery, gastric surgery, or any other condition lastly leading to PEI), who are willing to participate in the study and sign the informed consent are included.

Study variables. Demographics, toxic habits and pharmacological therapies; underlying disease causing PEI; methods used for PEI diagnosis; PEI-related complications; associated diagnosis and therapies; PEI therapy.

An Electronic Case Report Form (E-CRF) has been designed in RedCap. Patients’ data are included encoded to guarantee confidentiality.

Interventions. This is an observational study and it does influence clinical decision-making. Only data from clinical practice will be recorded.

< Back to News